Consolidated Balance Sheets - USD ($) $ in Millions	Nov. 30, 2025	Feb. 28, 2025
Current
Cash and cash equivalents (note 3)	$ 270.3	$ 266.7
Short-term Investments	33.9	71.1
Accounts Receivable, after Allowance for Credit Loss, Current	149.5	173.7
Other receivables (note 4)	48.7	48.4
Income taxes receivable	2.4	1.6
Other current assets (note 4)	38.4	30.0
Assets, Current, Total	543.2	591.5
Restricted cash and cash equivalents (note 3)	14.0	13.6
Long-term investments (note 3)	59.3	58.9
Other long-term assets (note 4)	53.7	76.5
Operating lease right-of-use assets, net	17.7	22.0
Property, plant and equipment, net (note 4)	11.7	13.4
Intangible assets, net (note 4)	40.7	47.3
Goodwill (note 4)	478.1	472.4
Assets	1,218.4	1,295.6
Current
Accounts payable	13.4	31.1
Accrued liabilities (note 4)	106.1	126.2
Income taxes payable (note 5)	12.5	25.5
Deferred revenue, current (note 11)	121.3	161.5
Total current liabilities	253.3	344.3
Deferred revenue, non-current (note 11)	4.8	5.6
Operating lease liabilities	21.2	28.7
Other long-term liabilities	1.8	1.8
Long-Term Debt	196.2	195.3
Total liabilities	477.3	575.7
Capital stock and additional paid-in capital
Preferred shares: authorized unlimited number of non-voting, cumulative, redeemable and retractable	0.0	0.0
Common shares: authorized unlimited number of non-voting, redeemable, retractable Class A common shares and unlimited number of voting common shares Issued - 590,392,106 voting common shares (February 28, 2025 - 596,230,655)	2,953.8	2,976.4
Deficit	(2,199.6)	(2,237.3)
Accumulated other comprehensive loss (note 9)	(13.1)	(19.2)
Total shareholders' equity	741.1	719.9
Total liabilities and shareholders' equity	$ 1,218.4	$ 1,295.6
Common issued (in shares)	590,392,106	596,230,655
Common outstanding (in shares)	590,392,106	596,230,655